EVOLVING CONCEPTS IN MOLECULAR PATHOLOGY

被引:7
作者
KAPPEL, CA [1 ]
BIEBERICH, CJ [1 ]
JAY, G [1 ]
机构
[1] AMER RED CROSS, JEROME H HOLLAND LAB, VIROL LAB, ROCKVILLE, MD 20855 USA
关键词
TRANSGENIC MICE; GENE EXPRESSION; HUMAN DISEASE; ANIMAL MODELS;
D O I
10.1096/fasebj.8.9.8005386
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During the last decade, an understanding of the causes of many human diseases has progressed rapidly, in large measure because of the development of technologies that allow us to identify the genes that are involved. Identification of a gene that is suspected to play an important role in a particular disease opens up a whole new dimension of research to understand the molecular events that underlie the cause of that disorder. A crucial step in this process is often the development of an animal model of the disease. Again, the last decade has seen rapid advances in our ability to create such models, particularly in mice. Technologies that allow for the addition, alteration, of elimination of individual genes from the genome to create a transgenic mouse are now routine. The advantages of having a transgenic mouse model of a human disease are many. These animals often provide the first unequivocal proof that a particular gene is responsible for causing the pathological changes that occur with disease. They also can provide a system to carefully dissect the successive events that lead to the disease state, and can provide a custom-designed whole animal system to test potential therapies to treat and eventually cure the disease. Most important, new concepts relating to gene expression and gene function in disease often emerge from such transgenic studies. This review will illustrate several examples in which transgenic animals have contributed significantly to the evolution of concepts of the underlying mechanisms of human disease.
引用
收藏
页码:583 / 592
页数:10
相关论文
共 40 条
[1]   TRANSGENIC MODELS OF TUMOR-DEVELOPMENT [J].
ADAMS, JM ;
CORY, S .
SCIENCE, 1991, 254 (5035) :1161-1167
[2]   THE EXPRESSION OF MUTANT EPIDERMAL KERATIN CDNAS TRANSFECTED IN SIMPLE EPITHELIAL AND SQUAMOUS-CELL CARCINOMA LINES [J].
ALBERS, K ;
FUCHS, E .
JOURNAL OF CELL BIOLOGY, 1987, 105 (02) :791-806
[3]   EXPRESSION OF MUTANT KERATIN CDNAS IN EPITHELIAL-CELLS REVEALS POSSIBLE MECHANISMS FOR INITIATION AND ASSEMBLY OF INTERMEDIATE FILAMENTS [J].
ALBERS, K ;
FUCHS, E .
JOURNAL OF CELL BIOLOGY, 1989, 108 (04) :1477-1493
[4]   CLONING THE CHROMOSOMAL BREAKPOINT OF T(14-18) HUMAN LYMPHOMAS - CLUSTERING AROUND JH ON CHROMOSOME-14 AND NEAR A TRANSCRIPTIONAL UNIT ON 18 [J].
BAKHSHI, A ;
JENSEN, JP ;
GOLDMAN, P ;
WRIGHT, JJ ;
MCBRIDE, OW ;
EPSTEIN, AL ;
KORSMEYER, SJ .
CELL, 1985, 41 (03) :899-906
[5]   EPIDERMOLYSIS-BULLOSA SIMPLEX - EVIDENCE IN 2 FAMILIES FOR KERATIN GENE ABNORMALITIES [J].
BONIFAS, JM ;
ROTHMAN, AL ;
EPSTEIN, EH .
SCIENCE, 1991, 254 (5035) :1202-1205
[6]   TRANSGENIC MOUSE MODELS OF LIPOPROTEIN METABOLISM AND ATHEROSCLEROSIS [J].
BRESLOW, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) :8314-8318
[7]  
BRESLOW JL, 1993, CIRCULATION, V87, P16
[8]   TRANSGENIC MICE HARBORING SV40 T-ANTIGEN GENES DEVELOP CHARACTERISTIC BRAIN-TUMORS [J].
BRINSTER, RL ;
CHEN, HY ;
MESSING, A ;
VANDYKE, T ;
LEVINE, AJ ;
PALMITER, RD .
CELL, 1984, 37 (02) :367-379
[9]   ALTERING THE GENOME BY HOMOLOGOUS RECOMBINATION [J].
CAPECCHI, MR .
SCIENCE, 1989, 244 (4910) :1288-1292